Paul Parkinson - 14 May 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Fmr EVP Strategy & Innovation
Signature: By: Nathan A. Smith For: Paul Parkinson
Issuer symbol: MYGN
Transactions as of: 14 May 2021
Net transactions value: $0
Form type: 4
Filing time: 28 May 2021, 19:29:48 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						87,407	14 May 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Paul Parkinson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving as the Company's EVP Strategy and Innovation, effective as of May 14, 2021, and therefore is no longer subject to Section 16 reporting.